RU99118887A - Применение ингибиторов желудочно-кишечной липазы - Google Patents

Применение ингибиторов желудочно-кишечной липазы

Info

Publication number
RU99118887A
RU99118887A RU99118887/14A RU99118887A RU99118887A RU 99118887 A RU99118887 A RU 99118887A RU 99118887/14 A RU99118887/14 A RU 99118887/14A RU 99118887 A RU99118887 A RU 99118887A RU 99118887 A RU99118887 A RU 99118887A
Authority
RU
Russia
Prior art keywords
gastrointestinal lipase
application
lipase inhibitors
gastrointestinal
inhibitor
Prior art date
Application number
RU99118887/14A
Other languages
English (en)
Other versions
RU2201272C2 (ru
Inventor
Джонатан Брайан ХОПТМАН
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of RU99118887A publication Critical patent/RU99118887A/ru
Application granted granted Critical
Publication of RU2201272C2 publication Critical patent/RU2201272C2/ru

Links

Claims (4)

1. Применение ингибитора желудочно-кишечной липазы для приготовления лекарственных средств, назначаемых орально, для лечения или предупреждения сахарного диабета типа II.
2. Применение по п.1, где ингибитор желудочно-кишечной липазы представляет собой тетрагидролипстатин.
3. Лекарственное средство для орального введения, предназначенное для лечения или предупреждения сахарного диабета типа II, отличающееся тем, что оно содержит эффективное количество ингибитора желудочно-кишечной липазы.
4. Лекарственное средство для орального введения по п.3, где ингибитор желудочно-кишечной липазы представляет собой тетрагидролипстатин.
RU99118887/14A 1997-02-05 1998-01-29 Применение ингибиторов желудочно-кишечной липазы RU2201272C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
US60/037,383 1997-02-05

Publications (2)

Publication Number Publication Date
RU99118887A true RU99118887A (ru) 2001-05-20
RU2201272C2 RU2201272C2 (ru) 2003-03-27

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99118887/14A RU2201272C2 (ru) 1997-02-05 1998-01-29 Применение ингибиторов желудочно-кишечной липазы

Country Status (28)

Country Link
US (1) US6147108A (ru)
EP (1) EP1017408B1 (ru)
JP (1) JP2001509173A (ru)
KR (1) KR100479968B1 (ru)
CN (1) CN1154505C (ru)
AR (1) AR011106A1 (ru)
AT (1) ATE292975T1 (ru)
AU (1) AU740375B2 (ru)
BR (1) BR9807655A (ru)
CA (1) CA2278854C (ru)
CZ (1) CZ295567B6 (ru)
DE (1) DE69829763T2 (ru)
DK (1) DK1017408T3 (ru)
ES (1) ES2239799T3 (ru)
HK (1) HK1025251A1 (ru)
HU (1) HU230834B1 (ru)
ID (1) ID22650A (ru)
IL (1) IL131007A0 (ru)
ME (1) ME00578A (ru)
NO (1) NO324452B1 (ru)
NZ (1) NZ336755A (ru)
PL (1) PL191222B1 (ru)
PT (1) PT1017408E (ru)
RU (1) RU2201272C2 (ru)
TR (1) TR199901853T2 (ru)
WO (1) WO1998034630A1 (ru)
YU (1) YU34199A (ru)
ZA (1) ZA98753B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1017408B1 (en) * 1997-02-05 2005-04-13 F. Hoffmann-La Roche Ag Use of tethrahydrolipstatin in the treatment of diabetes type ii
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
EP2626368B1 (en) 2004-07-19 2016-12-21 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
CA2604653A1 (en) 2005-04-13 2006-10-19 Glucolight Corporation Method for data reduction and calibration of an oct-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
EP2036575B1 (en) * 2007-09-12 2010-08-18 Mader S.r.l. Pharmaceutical compositions for oral use for treating patients affected by obesity
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
AU2008313248B2 (en) 2007-10-16 2012-04-26 Biocon Limited An orally administerable solid pharmaceutical composition and a process thereof
US8768423B2 (en) 2008-03-04 2014-07-01 Glt Acquisition Corp. Multispot monitoring for use in optical coherence tomography
US8309107B2 (en) * 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP2019515654A (ja) * 2016-03-16 2019-06-13 ザ ジェイ． デヴィッド グラッドストーン インスティテューツ 肥満及び／又は糖尿病を処置するための方法及び組成物、並びに候補処置薬剤を識別するための方法及び組成物
US20190022061A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang Statins (Atorvastatin) can lower blood sugar level in diabetic

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
EP1017408B1 (en) * 1997-02-05 2005-04-13 F. Hoffmann-La Roche Ag Use of tethrahydrolipstatin in the treatment of diabetes type ii
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions

Similar Documents

Publication Publication Date Title
RU99118887A (ru) Применение ингибиторов желудочно-кишечной липазы
CA2214033A1 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
CA2186039A1 (en) New oral pharmaceutical dosage form
SE9600070D0 (sv) New oral pharmaceutical dosage forms
AR014467A1 (es) Unidad de dosis farmaceutica oralmente administrable de un tamano superior a 7 mm que comprende una droga y un recubrimiento externo, un metodo paraseparar una unidad de dosis farmaceutica oralmente administrable a partir de un alimento co-administrado y el uso de una droga y un material de recubrim
CA2106172A1 (en) Use of 2-(3,4-Dimethoxycinnamoyl)Aminobenzoic Acid for the Treatment of Restenosis Associated with Coronary Intervention
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
BR9506028A (pt) Forma farmacêutica oral de múltipla dosagem unitária em tablete processos para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem e para o tratamento das doenças inflamatórias gastrointestinais em mamiíferos e no homem e embalagem de ampola de pressão transversal
CA2382387A1 (en) Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
CA2377174A1 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
HUP9802795A2 (hu) Elhízás kezelésére alkalmas, béta-adrenerg ágenst és étvágycsökkentő hatású vegyületet tartalmazó gyógyászati készítmények
BR9807655A (pt) Uso de inibidores de lipase gastrintestinal.
BE901073A (fr) Composition antidiuretique a usage oral.
EP0375628A3 (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
RU98116126A (ru) Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний
EP0657167A3 (fr) Application de l'oenothéine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, les compositions pharmaceutiques le contenant et un procédé de préparation à partir d'Epilobium Parviflorum.
EP1295875A4 (en) HETEROCYCLIC COMPOUNDS
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
DZ2564A1 (fr) Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés.
KR870009716A (ko) 클로르페니라민 제형